Latest filing published 12 Feb 2021 for GlaxoSmithKline plc.
Insider track record
I Mackay: trading record in brief
This profile gathers the share dealings of I Mackay in GlaxoSmithKline plc. In total, 9 filings cover trades dated from 8 March 2019 to 10 February 2021.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 12 February 2021, the filings show a share grant in GlaxoSmithKline plc. The median gap between a trade and its publication by RNS (LSE) is 2 days. The regulation allows three business days to notify a trade (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to I Mackay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 31,725 sharesN/AISIN GB0009252882FCA-NSM:3878373-1
- 278,363 shares@ £12.77N/AISIN GB0009252882FCA-NSM:3878367-1
- 499 shares@ £13.934London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3851939-8
- 482 shares@ £14.254London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3748390-8
- 426 shares@ £15.928100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3657059-8
- 524 shares@ £15.442London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3564578-8
- 207,267 shares@ £16.81499.8% of flowN/AISIN GB0009252882FCA-NSM:LSE20200219162845_3499497_20200331164942435_18543-8
- 35,223 sharesN/AISIN GB0009252882FCA-NSM:LSE20200219161740_3499482_20200331164942434_18534-7
- 225,255 shares@ £15.12448.7% of flown/aISIN GB0009252882FCA-NSM:LSE20190311182400_13997969_20200326185134137_20469-5
9 of 9 declarations